If you wish to report an adverse event or product complaint, please call 1-800-LILLYRX (1-800-545-5979)
This information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.
Baqsimi has not been studied for use as a diagnostic agent in the radiologic examination of the stomach, small intestine, or colon when temporary diminished intestinal motility would be advantageous. Thus, Eli Lilly and Company has no information on the use of Baqsimi for this testing.
Enclosed Prescribing Information
Baqsimi = Baqsimi™ (glucagon) nasal powder
Date of Last Review: July 24, 2019